Pfizer submits trademark application that suggests it could be launching a direct-to-patient program
Pfizer may be the next pharma giant to launch a direct-to-consumer platform.
The company applied in April to trademark “Pfizer for All” for a number …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
